Mediclinic International Plc

Public consensus   -   Last updated 08/10/20

Contributors

  • 7 1H FY21 based on
  • 7 FY21 based on
  • 7 FY22 based on
  • 7 FY23 based on
Reporting currency: GBP
Reporting unit: Absolute
1H FY21
CONSENSUS
08/10/20
FY21
CONSENSUS
08/10/20
FY22
CONSENSUS
08/10/20
FY23
CONSENSUS
08/10/20
Hirslanden (CHF'm) - Adjusted
Revenue
829
1,769
1,841
1,869
EBITDA
101
269
309
314
EBITDA margin (%)
12.2
15.2
16.8
16.8
Average FX rate GBP/CHF
1.20
1.21
1.21
1.21
Southern Africa (ZAR'm) - Adjusted
Revenue
7,131
15,758
17,829
18,988
EBITDA
792
2,455
3,527
3,844
EBITDA margin (%)
11.1
15.5
19.8
20.2
Average FX rate GBP/ZAR
21.75
21.57
21.80
22.07
Middle East (AED'm) - Adjusted
Revenue
1,494
3,379
3,678
3,903
EBITDA
148
447
585
648
EBITDA margin (%)
9.9
13.2
15.9
16.6
Average FX rate GBP/AED
4.67
4.68
4.69
4.70
Adjusted Group (GBP'm)
Revenue
1,337
2,912
3,126
3,233
EBITDA
151
430
541
569
EBITDA margin (%)
11.3
14.8
17.3
17.6
Operating profit
n/a
211
319
344
Earnings per share (pence)
n/a
12.3
24.2
27.9
Dividend per share (pence)
n/a
2.8
6.2
7.0
Net Debt
n/a
2,095
1,959
1,821
Net cash generated from operating activities
n/a
303
374
406
Total Group Capex
n/a
195
207
215

Disclaimer

Mediclinic International plc (“Mediclinic”) does not endorse or adopt any of the consensus estimates expressed in this report. The report represents the views of analysts from which the consensus estimates are derived. Mediclinic will not provide any commentary on the consensus or answer questions on it. The circulation of the consensus by Mediclinic is not mandatory and Mediclinic may amend its practice on this at any time.